$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Nov 26, 2025)
$4.13B
Market Cap
15.44
P/E Ratio
1.58
EPS
$26.65
52 Week High
$13.40
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
ACADIA Pharmaceuticals Inc. is a leading biopharmaceutical company headquartered in San Diego, California, focused on developing and commercializing innovative therapies for central nervous system disorders. The company has established a strong pipeline of small molecule drugs aimed at addressing critical unmet medical needs, especially in treating Parkinson's disease psychosis and schizophrenia. ACADIA's dedication to scientific innovation, supported by strategic partnerships, enhances its position within the competitive healthcare landscape, targeting improved patient outcomes while fostering sustainable growth in the biopharmaceutical industry.
LPTX
VHAI
NVDA
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
BTBT
GRAB
RIG
IVP
PFE
AGNC
GOOG
CCL
PLTR
SNAP
AVGO
RGTI
VALE
MTSR
NFLX
PLTD
T
IREN
NTNX
MSFT
ITUB
ORCL
HBAN
BAC
TLRY
DVLT
PCG
QBTS
NOK
HBI
HPQ
IPG
CAN
APLD
MNDR
SMCI
LPTX
VHAI
NVDA
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
BTBT
GRAB
RIG
IVP
PFE
AGNC
GOOG
CCL
PLTR
SNAP
AVGO
RGTI
VALE
MTSR
NFLX
PLTD
T
IREN
NTNX
MSFT
ITUB
ORCL
HBAN
BAC
TLRY
DVLT
PCG
QBTS
NOK
HBI
HPQ
IPG
CAN
APLD
MNDR
SMCI